Progress 09/01/17 to 08/31/22
Outputs
Target Audience:Ruminant industry, veterinarians and rural mixed animal practitioners. Changes/Problems:Final RACE accreditation has been delayed due to faculty turnover and retirements. We will complete this final part of the project in the coming year. What opportunities for training and professional development has the project provided?Our final aim was to recruit new graduates into a food animal internship that would prepare them to enter rural food animal practice. We have successfully trained one intern animal practice. We have successfully trained one intern each year of the grant. Four of the interns went into large animal practice upon completion--one each in North Carolina, Pennsylvania, Colorado, and Oregon. The fifth intern, Cambrey Knapp, completed her internship in Ruminant Health and entered a PhD program at Oregon State investigating disease transmission between domestic and wild ruminants. The success of this internship program has led the NC State University College of Veterinary Medicine to not only take over complete funding of the position, but also add a second position starting the summer of 2023. These positions will be funded through recurring state funds so we anticipate this program to continue to grow and be sustained. How have the results been disseminated to communities of interest?Our second aim was to create online training modules to provide practitioners who could not attend in person continuing education an alternative avenue to access this information. We have developed 4 online modules: Legal Extralabel Drug Use in Food Animals, Estimating Withdrawal Intervals, Extralabel Drug Use in Poultry, and Extralabel Drug Use in Small Ruminants. We focused two modules on poultry and small ruminants as those species are now the majority of requests that FARAD receives. Due to COVID delays, these modules are not RACE approved yet, but will be in 2023. Once approved, they will be freely available to practitioners. The modules will be hosted by NC State and accessed through the FARAD website. Both the AVMA and VMX (formerly North American Veterinary Conference) are developing online CE portals for veterinarians and will point interested practitioners to our modules once they are available. In the meantime, recorded versions of the CE presentation developed in aim 1 have been made available electronically through both VMX and the NC State CE office. Once these modules are complete, NC State will continue to host and maintain them, and we will be able to track participation. What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts
What was accomplished under these goals?
Our USDA-NIFA Veterinary Services Grant "Training rural mixed animal veterinarians in residue avoidance with support of a new collaborative food animal medicine internship" proposed 3 aims. The overarching goal was to improve rural practitioners' confidence in legally prescribing drugs to food animals. This would have a two fold effect: one, more veterinarians would be comfortable treating these animals and therefore access to care would increase, and two, food safety would improve if those veterinarians better understood the concepts around withdrawal times. Aim 1 was to provide continuing education to mixed animal and small animal practitioners on the topic of extralabel drug use and withdrawal intervals. We targeted national and regional meetings across the United States, and our team gave this presentation at 6 large continuing education meetings. These included the three largest CE events in the US: the AVMA convention, Western Veterinary Conference, and North American Veterinary Conference (now VMX). Attendees were asked to complete a pre- and post-test at these presentations. From those who completed the form, we can document that we reached practitioners in 28 different states. 52% of the attendees were companion animal practitioners, and 17% were mixed animal practitioners, so 2/3s of our attendees were our target audience. After the presentation, correct responses on the quiz increased for all areas. There was an increase of 28% in correct answers on questions about the role of FARAD, an increase of 39% on questions about legal requirements for extralabel drug use, an increase of 21% on questions about defining extralabel drug use, and an increase of 29% on questions asking participants to estimate a withdrawal interval. The other measure of success for this aim is an increased demand for FARAD's services. Over the 4 years of this grant, there has been an 18% increase in the requests for assistance from practitioners to FARAD. We feel that this outreach has been highly successful and will carry on as we are now being invited to give this presentation at other regional continuing education meetings.
Publications
|
Progress 09/01/20 to 08/31/21
Outputs
Target Audience:Ruminant industry, veterinarians and rural mixed animal practitioners. Changes/Problems:COVID prevented attendance at any major CE conferences this past year, so Dr. Foster presented the information via a recorded lecture as a part of the virtual VMX conference. Significant changes in clinical duties and teaching responsibilities at NC State due to COVID changes prevented the completion of the final module on extralabel drug use in small ruminants. This will be completed this coming year, and all modules will be submitted for RACE accreditation. What opportunities for training and professional development has the project provided?Due to COVID restrictions, our ability to travel to meetings and provide continuing education lectures has been curtailed. Nonetheless, Dr. Foster provided a virtual seminar for the annual VMX conference this past year. This conference is one of the largest veterinary CE conferences in the country each year. We have also completed two additional modules for online CE on drug use. One on withdrawal interval calculation and another on extralabel drug use in poultry. These will be submitted for RACE accreditation this coming year and made available to practitioners. How have the results been disseminated to communities of interest?The lecture for VMX was provided for all registered participants in the virtual conference last year. The online modules will be made available to practitioners in the coming year after RACE certification. What do you plan to do during the next reporting period to accomplish the goals?In the coming year with a NCE, we will complete the final online module on extralabel drug use in small ruminants and all four modules will be submitted for RACE certification.
Impacts
What was accomplished under these goals?
Due to COVID restrictions, our ability to travel to meetings and provide continuing education lectures has been curtailed. Nonetheless, Dr. Foster provided a virtual seminar for the annual VMX conference this past year. This conference is one of the largest veterinary CE conferences in the country each year. We have also completed two additional modules for online CE on drug use. One on withdrawal interval calculation and another on extralabel drug use in poultry. These will be submitted for RACE accreditation this coming year and made available to practitioners. Allison Hoch completed her internship in Ruminant Health and is now pursuing large animal practice in Oregon.
Publications
|
Progress 09/01/19 to 08/31/20
Outputs
Target Audience:Ruminant industry, veterinarians and rural mixed animal practitioners. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?Aim 2: Create online training modules on residue avoidance. The first online module has been completed, and the second is under review by the collaborators. These will be submitted for RACE accreditation and provided free of charge through the AVMA, VMX, and FARAD. How have the results been disseminated to communities of interest?Seminars. Based on the responses to the Google survey, we have reached veterinarians from at least 25 states. Two-thirds of the attendees have been mixed animal or small animal practitioners that we were trying to target. Prior to the seminar, only 70% of attendees could correctly identify the role of FARAD, whereas afterwards it was 97%. Only 50% of attendees understood when extralabel drug use was appropriate prior to the seminar, whereas 95% did afterwards. Attendee performance similarly increased on questions regarding the definition of extralabel drug use and the impact of dosing regimen on withdrawal times. What do you plan to do during the next reporting period to accomplish the goals?Training and professional development for Dr. Blanca Camacho. She has started as a new resident in ruminant health, and a new intern will be starting next June. We will be providing virtual seminar through the VMX meeting in Orlando this January.
Impacts
What was accomplished under these goals?
Aim 1: Provide targeted continuing education seminars on residue avoidance for non-food animal practitioners. This past year we have provided seminars through the NC State College of Veterinary Medicine Continuing Education office that was attended by 35 people in person and 27 remotely. We also provided seminars at the AVMA Convention that was attended by 70 people. Other related seminars include: Sunday, March 10 2019, UC Davis Avian Exotics Symposium: The Ins and Outs of Extra Label Drug Use in Backyard Poultry; Small Ruminant Pharmacology and drug withdrawals" at the Southeast Veterinary Conference June 21-24, 2020. We will be recording a presentation to include in the VMX meeting in January 2021. Aim 1: Provide targeted continuing education seminars on residue avoidance for non-food animal practitioners. This past year we have provided seminars through the NC State College of Veterinary Medicine Continuing Education office that was attended by 35 people in person and 27 remotely. We also provided seminars at the AVMA Convention that was attended by 70 people. Other related seminars include: The Ins and Outs of Extra Label Drug Use in Backyard Poultry; Small Ruminant Pharmacology and drug withdrawals" at the Southeast Veterinary Conference June 21-24, 2020. We will be recording a presentation to include in the VMX meeting in January 2021.
Publications
|
Progress 09/01/18 to 08/31/19
Outputs
Target Audience:Ruminant industry, veterinarians and rural mixed animal practitioners. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?Dr. Rose Digiantonio completed her internship at NC State in June, and has joined a mixed animal practice in rural southern Colorado. Her practice area overlaps with shortage area CO 193. We have recently hired Dr. Allison Hoch as a new intern in ruminant health. She is a graduate of the University College Dublin School of Veterinary Medicine. How have the results been disseminated to communities of interest?Seminars. Based on the responses to the Google survey, we have reached veterinarians from at least 25 states. Two-thirds of the attendees have been mixed animal or small animal practitioners that we were trying to target. Prior to the seminar, only 70% of attendees could correctly identify the role of FARAD, whereas afterwards it was 97%. Only 50% of attendees understood when extralabel drug use was appropriate prior to the seminar, whereas 95% did afterwards. Attendee performance similarly increased on questions regarding the definition of extralabel drug use and the impact of dosing regimen on withdrawal times. We currently have plans to present the seminar at local veterinary meetings in North Carolina and Kansas, and at the VMX (formerly North American Veterinary Conference) in Orlando. What do you plan to do during the next reporting period to accomplish the goals?Training and professional development for Dr. Allison Hoch. She has started as a new intern in ruminant health.
Impacts
What was accomplished under these goals?
Aim 2: Create online training modules on residue avoidance. During this year, we have identified a free online education software platform that will allow us to distribute the modules as they are created. We have completed the initial module on the legal restrictions on extralabel drug use, and it is currently being reviewed by the collaborators in FARAD prior to release. I have also secured preliminary agreements from both the AVMA and VMX conference to include our online modules in their online CE databases that are available to their audiences. This will broaden the reach of these modules to a diverse mix of practitioners across the country.
Publications
|
Progress 09/01/17 to 08/31/18
Outputs
Target Audience:Ruminant industry, veterinarians, and rural mixed animal practitioners. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?Aim 1: Speak at meeting in Kansas City and secure invitations to speak at future conferences. Aim 2: Complete modules 1 and 2. Aim 3: Continue training Dr. Digianantonio. Recruit intern for the following year.
Impacts
What was accomplished under these goals?
Aim 1: Secured invitations to speak at Fetch 360 in Kansas City in August 2018. Made contact with representatives with the AVMA convention, AAEP convention and Western Veterinary Conference about speaking in future years. Aim 2: Worked with educational consultant to outline the first module. Currently evaluationg software options. Aim 3: Hired Dr. Rose Digianantonio, veterinary intern.
Publications
|
|